The Present and FutureJACC State-of-the-Art ReviewOptimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week
JACC State-of-the-Art Review
Under a Creative Commons license
open access
Central Illustration
Key Words
clinical trials
device therapy
drug therapy
FDA
guideline directed medical therapy
heart failure
HFrEF
medical therapy
medication
Abbreviations and Acronyms
FDA
U.S. Food and Drug Administration
EF
ejection fraction
GDMT
guideline-directed medical therapy
HF
heart failure
HFpEF
heart failure with preserved ejection fraction
HFrEF
heart failure with reduced ejection fraction
Cited by (0)
Christie M. Ballantyne, MD, served as Guest Editor-in-Chief for this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.